Fop

Corteva Reports First Quarter 2023 Results, Raises Full-Year Guidance

Retrieved on: 
Mercoledì, Maggio 3, 2023
Pressure, Biologicals, Farmer, Rapeseed, Agriculture, Bunge, AG, GAAP, Carbon, Grain, Fop, Corteva, Crop protection, Weed control, Soil, Investment, Herbicide, Growth, Weather, EPS, RNA interference, Health, Choline, Chevron Corporation, Pharmaceutical industry, Drug, Renewable energy

INDIANAPOLIS, May 3, 2023 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the three months ended March 31, 2023.

Key Points: 
  • First quarter 2023 net sales rose 6% versus prior year with gains in both segments.
  • GAAP income and earnings per share (EPS) from continuing operations were $607 million and $0.84 per share for the first quarter 2023, respectively.
  • "Corteva delivered a solid start to 2023, reflecting focused execution coupled with continued demand for our innovative technology solutions.
  • Corteva expects net sales in the range of $18.6 billion to $18.9 billion, growth of 7% at the mid-point.